Hellmut Ottinger

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

Jürgen Finke, Wolfgang Bethge, Claudia Schmoor et al. · The Lancet Oncology · 2009 · 705 citations

Unrelated Donors, Graft-versus-host Disease, Transplantation +12

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

Ahmet Elmaağaclı, Nina K. Steckel, Michael Koldehoff et al. · Blood · 2011 · 310 citations · Full text

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius

Gèrard Socié, Claudia Schmoor, Wolfgang Bethge et al. · Blood · 2011 · 302 citations · Full text

Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias

Dietrich W. Beelen, Hellmut Ottinger, S. Ferenčík et al. · Blood · 2004 · 173 citations

Mutations in Innate Immune System NOD2/CARD 15 and TLR-4 (Thr399Ile) Genes Influence the Risk for Severe Acute Graft-versus-Host Disease in Patients Who Underwent an Allogeneic Transplantation

Ahmet Elmaağaclı, Michael Koldehoff, Heidrun Hindahl et al. · Transplantation · 2006 · 131 citations